BSE Live
Oct 27, 15:01Prev. Close
1677.85
Open Price
1686.20
Bid Price (Qty.)
1692.00 (30)
Offer Price (Qty.)
1729.00 (3)
NSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
| Profit & Loss account of Fredun Pharmaceuticals Limited (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 112.77 | 97.02 | 59.55 | 56.70 | 42.32 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue From Operations [Net] | 112.77 | 97.02 | 59.55 | 56.70 | 42.32 | |
| Total Operating Revenues | 112.77 | 97.02 | 59.55 | 56.70 | 42.32 | |
| Other Income | 0.52 | 0.39 | 0.16 | 1.91 | 0.86 | |
| Total Revenue | 113.29 | 97.40 | 59.71 | 58.61 | 43.18 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 85.86 | 65.96 | 42.98 | 34.20 | 30.42 | |
| Purchase Of Stock-In Trade | 0.00 | 0.00 | 0.00 | 0.00 | 0.83 | |
| Operating And Direct Expenses | 5.29 | 4.22 | 2.68 | 4.30 | 2.83 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -5.04 | -6.08 | -3.47 | 2.98 | -4.42 | |
| Employee Benefit Expenses | 8.95 | 8.04 | 5.19 | 4.92 | 3.83 | |
| Finance Costs | 4.41 | 3.10 | 1.94 | 1.87 | 2.06 | |
| Depreciation And Amortisation Expenses | 1.88 | 1.33 | 1.29 | 1.14 | 0.80 | |
| Other Expenses | 9.45 | 14.67 | 6.47 | 6.95 | 4.93 | |
| Total Expenses | 110.79 | 91.24 | 57.07 | 56.36 | 41.28 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 2.49 | 6.16 | 2.64 | 2.25 | 1.90 | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | -0.06 | |
| Profit/Loss Before Tax | 2.49 | 6.16 | 2.64 | 2.25 | 1.84 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 0.44 | 1.72 | 0.93 | 0.64 | 0.60 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | 0.15 | -0.02 | -0.04 | 0.16 | 0.16 | |
| Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | 0.59 | 1.70 | 0.89 | 0.80 | 0.77 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 1.90 | 4.46 | 1.75 | 1.45 | 1.07 | |
| Profit/Loss From Continuing Operations | 1.90 | 4.46 | 1.75 | 1.43 | 1.07 | |
| Profit/Loss For The Period | 1.90 | 4.46 | 1.75 | 1.43 | 1.07 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | 4.77 | 11.59 | 6.07 | 6.07 | 4.50 | |
| Diluted EPS (Rs.) | 4.77 | 11.59 | 6.07 | 6.07 | 4.50 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 0.00 | 0.26 | 0.67 | 0.14 | 0.14 | |
| Tax On Dividend | 0.00 | 0.05 | 0.14 | 0.07 | 0.03 | |
| Equity Dividend Rate (%) | 7.00 | 7.00 | 6.00 | 6.00 | 6.00 |
31.07.2025
Fredun Pharmace Standalone June 2025 Net Sales at Rs 119.40 crore, up 54% Y-o-Y
24.06.2025
Fredun Pharmace Standalone March 2025 Net Sales at Rs 165.44 crore, up 40.16% Y-o-Y
05.02.2025
Fredun Pharmace Standalone December 2024 Net Sales at Rs 101.84 crore, up 17.52% Y-o-Y
30.07.2024
Fredun Pharmace Standalone June 2024 Net Sales at Rs 77.54 crore, up 26.64% Y-o-Y
31.07.2025
Fredun Pharmace Standalone June 2025 Net Sales at Rs 119.40 crore, up 54% Y-o-Y
24.06.2025
Fredun Pharmace Standalone March 2025 Net Sales at Rs 165.44 crore, up 40.16% Y-o-Y
05.02.2025
Fredun Pharmace Standalone December 2024 Net Sales at Rs 101.84 crore, up 17.52% Y-o-Y
30.07.2024
Fredun Pharmace Standalone June 2024 Net Sales at Rs 77.54 crore, up 26.64% Y-o-Y